These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32052893)

  • 1. Transvenous lead extraction after heart transplantation: How to avoid abandoned lead fragments.
    Hahnel F; Pecha S; Bernhardt A; Barten MJ; Chung DU; Sinning C; Willems S; Reichenspurner H; Hakmi S
    J Cardiovasc Electrophysiol; 2020 Apr; 31(4):854-859. PubMed ID: 32052893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel extraction technique of retained pacemaker and defibrillator lead during heart transplantation.
    Hasumi E; Fujiu K; Kojima T; Kinoshita O; Nawata K; Yamauchi H; Ono M; Komuro I
    PLoS One; 2018; 13(9):e0203172. PubMed ID: 30188917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Systematic Review of Short-Term Outcomes of Leadless Pacemaker Implantation After Transvenous Lead Removal of Infected Cardiac Implantable Electronic Device.
    Tan MC; Tan JL; Tay ST; Sorajja D; Scott L; Cha YM; Russo AM; Hussein A; Lee JZ
    Am J Cardiol; 2023 Sep; 203():444-450. PubMed ID: 37542954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post heart transplant extraction of the abandoned fragments of pacing and defibrillation leads: proposed management algorithm.
    Kuśmierski K; Przybylski A; Oręziak A; Sobieszczańska-Małek M; Kołsut P; Różański J
    Kardiol Pol; 2013; 71(2):159-63. PubMed ID: 23575709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procedural outcomes associated with transvenous lead extraction in patients with abandoned leads: an ESC-EHRA ELECTRa (European Lead Extraction ConTRolled) Registry Sub-Analysis.
    Segreti L; Rinaldi CA; Claridge S; Svendsen JH; Blomstrom-Lundqvist C; Auricchio A; Butter C; Dagres N; Deharo JC; Maggioni AP; Kutarski A; Kennergren C; Laroche C; Kempa M; Magnani A; Casteigt B; Bongiorni MG;
    Europace; 2019 Apr; 21(4):645-654. PubMed ID: 30624715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transvenous extraction of permanent pacemaker and defibrillator leads: Reduced procedural complexity and higher procedural success rates in patients with infective versus noninfective indications.
    Archontakis S; Pirounaki M; Aznaouridis K; Karageorgopoulos D; Sideris K; Tolios P; Triantafyllou K; Gatzoulis K; Tousoulis D; Sideris S
    J Cardiovasc Electrophysiol; 2021 Feb; 32(2):491-499. PubMed ID: 33345428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical Management of Cardiac Implantable Electronic Device Complications in Patients Unsuitable for Transvenous Lead Extraction.
    Miyagi Y; Oomori H; Maeda M; Murata T; Ota K; Motoji Y; Amitani R; Ueda H; Morishima M; Matsuyama T; Kurita J; Maruyama Y; Sasaki T; Sakamoto SI; Ishii Y
    Circ J; 2022 Dec; 87(1):103-110. PubMed ID: 36476494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Implantable Electronic Device Infections: Added Complexity and Suboptimal Outcomes With Previously Abandoned Leads.
    Hussein AA; Tarakji KG; Martin DO; Gadre A; Fraser T; Kim A; Brunner MP; Barakat AF; Saliba WI; Kanj M; Baranowski B; Cantillon D; Niebauer M; Callahan T; Dresing T; Lindsay BD; Gordon S; Wilkoff BL; Wazni OM
    JACC Clin Electrophysiol; 2017 Jan; 3(1):1-9. PubMed ID: 29759687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead extraction for cardiac implantable electronic device infection: comparable complication rates with or without abandoned leads.
    Bracke F; Verberkmoes N; van 't Veer M; van Gelder B
    Europace; 2019 Sep; 21(9):1378-1384. PubMed ID: 31324910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retained pacemaker and implantable cardioverter-defibrillator components after heart transplantation are common and may lead to adverse events.
    Pettit SJ; Orzalkiewicz M; Nawaz MA; Lewis C; Parameshwar J; Tsui S
    Europace; 2018 Aug; 20(8):1312-1317. PubMed ID: 29016986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid transvenous lead extraction during cardiac surgery for valvular endocarditis.
    Yildirim Y; Petersen J; Tönnis T; Reichenspurner H; Pecha S
    J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2101-2106. PubMed ID: 32478463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of standard and modified transvenous techniques for complex pacemaker lead extractions in the context of cardiac implantable electronic device-related infections: a 10-year experience.
    Zhou X; Jiang H; Ma J; Bakhai A; Li J; Zhang Y; Li Y; Wang D; Zhang Y; Xu G; Zhang J; Tang B
    Europace; 2013 Nov; 15(11):1629-35. PubMed ID: 23887094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Abandoned Leads on Cardiovascular Implantable Electronic Device Infections: A Propensity Matched Analysis of MEDIC (Multicenter Electrophysiologic Device Infection Cohort).
    Boyle TA; Uslan DZ; Prutkin JM; Greenspon AJ; Baddour LM; Danik SB; Tolosana JM; Le K; Miro JM; Peacock JE; Sohail MR; Vikram HR; Carrillo RG;
    JACC Clin Electrophysiol; 2018 Feb; 4(2):201-208. PubMed ID: 29749938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcutaneous lead implantation connected to an externalized pacemaker in patients with implantable cardiac defibrillator/pacemaker infection and pacemaker dependency.
    Pecha S; Aydin MA; Yildirim Y; Sill B; Reiter B; Wilke I; Reichenspurner H; Treede H
    Europace; 2013 Aug; 15(8):1205-9. PubMed ID: 23426553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience of cardiac implantable electronic device lead removal from a South African tertiary referral centre.
    Mkoko P; Mdakane NX; Govender G; Scherman J; Chin A
    Cardiovasc J Afr; 2021 Jul-Aug 23; 32(4):193-197. PubMed ID: 33950067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lead extraction for device related infections: a single-centre experience.
    Bracke FA; Meijer A; van Gelder LM
    Europace; 2004 May; 6(3):243-7. PubMed ID: 15121078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of outcomes in infected cardiovascular implantable electronic devices between complete, partial, and failed lead removal: an ESC-EHRA-EORP ELECTRa (European Lead Extraction ConTrolled) registry.
    Nof E; Bongiorni MG; Auricchio A; Butter C; Dagres N; Deharo JC; Rinaldi CA; Maggioni AP; Kutarski A; Kennergren C; Laroche C; Milman A; Beinart R; Bogdan S; Mortsell D; Calvi V; Desiron Q; Mansourati J; Blomstrom Lundqvist C; Glikson M;
    Europace; 2019 Dec; 21(12):1876-1889. PubMed ID: 31625553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epicardial pacemaker as a bridge for pacemaker-dependent patients undergoing explantation of infected cardiac implantable electronic devices.
    Al-Maisary SSA; Romano G; Karck M; De Simone R
    J Card Surg; 2019 Jun; 34(6):424-427. PubMed ID: 31017328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcatheter aspiration of large pacemaker and implantable cardioverter-defibrillator lead vegetations facilitating safe transvenous lead extraction.
    Starck CT; Schaerf RHM; Breitenstein A; Najibi S; Conrad J; Berendt J; Esmailian F; Eulert-Grehn J; Dreizler T; Falk V
    Europace; 2020 Jan; 22(1):133-138. PubMed ID: 31638648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of repeated transvenous lead extraction.
    Fu H; Ho G; Yang M; Huang X; Fender EA; Mulpuru S; Asirvatham R; Pretorius VG; Friedman PA; Birgersdotter-Green U; Cha YM
    Pacing Clin Electrophysiol; 2018 Oct; 41(10):1321-1328. PubMed ID: 30058073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.